Rankings
▼
Calendar
GPCR Q4 2025 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
$24M
Net Income
$33M
EPS (Diluted)
$0.60
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$64M
Free Cash Flow
-$66M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$68M
Stockholders' Equity
$1.5B
Cash & Equivalents
$800M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
$24M
-$47M
+151.0%
Net Income
$33M
-$36M
+190.5%
← FY 2025
All Quarters